(Q44524738)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Silvio Marco Veronese

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Orazio Caffo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Claudio Doglioni

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Mattia Barbareschi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Daniela Aldovini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Maria Giulia Cangi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Lorenza Pecciarini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Francesco Angelo Mauri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Antonio Lucenti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Paolo Dalla Palma

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Enzo Galligioni

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

number of pages

10

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

474-483

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12879463%20AND%20SRC:MED&resulttype=core&format=json

Heparan sulfate proteoglycans: intricate molecules with intriguing functions.

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

Syndecan-regulated receptor signaling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

Functions of cell surface heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

Molecular interactions of the syndecan core proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

Heparan sulfate-mediated cell aggregation. Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

HER2. a 'predictive factor' ready to use in the daily management of breast cancer patients?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

Soluble and matrix-associated heparan sulfate proteoglycans increase expression of erb-B2 and erb-B3 in colon cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11515

7 January 2021